336 related articles for article (PubMed ID: 11786904)
1. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
Asakura M; Kitakaze M; Takashima S; Liao Y; Ishikura F; Yoshinaka T; Ohmoto H; Node K; Yoshino K; Ishiguro H; Asanuma H; Sanada S; Matsumura Y; Takeda H; Beppu S; Tada M; Hori M; Higashiyama S
Nat Med; 2002 Jan; 8(1):35-40. PubMed ID: 11786904
[TBL] [Abstract][Full Text] [Related]
2. [Membrane-anchored heparin-binding EGF-like growth factor processing by ADAM12 in cardiac hypertrophy].
Higashiyama S
Nihon Rinsho; 2003 May; 61(5):767-75. PubMed ID: 12755001
[TBL] [Abstract][Full Text] [Related]
3. [The role of HB-EGF in angiotensin II--signaling].
Asakura M; Kitakaze M
Nihon Rinsho; 2002 Oct; 60(10):1916-21. PubMed ID: 12397684
[TBL] [Abstract][Full Text] [Related]
4. Shedding growth factors in cardiac hypertrophy.
Liao JK
Nat Med; 2002 Jan; 8(1):20-1. PubMed ID: 11786898
[No Abstract] [Full Text] [Related]
5. G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor.
Mifune M; Ohtsu H; Suzuki H; Nakashima H; Brailoiu E; Dun NJ; Frank GD; Inagami T; Higashiyama S; Thomas WG; Eckhart AD; Dempsey PJ; Eguchi S
J Biol Chem; 2005 Jul; 280(28):26592-9. PubMed ID: 15905175
[TBL] [Abstract][Full Text] [Related]
6. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
7. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
[TBL] [Abstract][Full Text] [Related]
8. Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.
Miller MA; Moss ML; Powell G; Petrovich R; Edwards L; Meyer AS; Griffith LG; Lauffenburger DA
Sci Rep; 2015 Oct; 5():15150. PubMed ID: 26477568
[TBL] [Abstract][Full Text] [Related]
9. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors.
Yan Y; Shirakabe K; Werb Z
J Cell Biol; 2002 Jul; 158(2):221-6. PubMed ID: 12119356
[TBL] [Abstract][Full Text] [Related]
10. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
Higashiyama S; Nanba D
Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle.
Zhang H; Chalothorn D; Jackson LF; Lee DC; Faber JE
Circ Res; 2004 Nov; 95(10):989-97. PubMed ID: 15486316
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological role of HB-EGF shedding by angiotensin II in cardiomyocytes].
Takashima S
Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):69-75. PubMed ID: 15277724
[TBL] [Abstract][Full Text] [Related]
13. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.
Prenzel N; Zwick E; Daub H; Leserer M; Abraham R; Wallasch C; Ullrich A
Nature; 1999 Dec 23-30; 402(6764):884-8. PubMed ID: 10622253
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinase (MAPK) regulates leukotriene D4-induced HB-EGF and ADAM12 expression in human airway smooth muscle cells.
Kumasawa F; Hashimoto S; Mizumura K; Takeshita I; Onose A; Jibiki I; Maruoka S; Gon Y; Kobayashi T; Takahashi N
Asian Pac J Allergy Immunol; 2013 Mar; 31(1):58-66. PubMed ID: 23517395
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.
Uchiyama-Tanaka Y; Matsubara H; Nozawa Y; Murasawa S; Mori Y; Kosaki A; Maruyama K; Masaki H; Shibasaki Y; Fujiyama S; Nose A; Iba O; Hasagawa T; Tateishi E; Higashiyama S; Iwasaka T
Kidney Int; 2001 Dec; 60(6):2153-63. PubMed ID: 11737589
[TBL] [Abstract][Full Text] [Related]
17. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
[TBL] [Abstract][Full Text] [Related]
18. A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation.
Yahata Y; Shirakata Y; Tokumaru S; Yang L; Dai X; Tohyama M; Tsuda T; Sayama K; Iwai M; Horiuchi M; Hashimoto K
J Biol Chem; 2006 May; 281(19):13209-13216. PubMed ID: 16543233
[TBL] [Abstract][Full Text] [Related]
19. A disintegrin and metalloproteinase 12 prevents heart failure by regulating cardiac hypertrophy and fibrosis.
Nakamura Y; Kita S; Tanaka Y; Fukuda S; Obata Y; Okita T; Kawachi Y; Tsugawa-Shimizu Y; Fujishima Y; Nishizawa H; Miyagawa S; Sawa Y; Sehara-Fujisawa A; Maeda N; Shimomura I
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H238-H251. PubMed ID: 31774689
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway.
Hao L; Du M; Lopez-Campistrous A; Fernandez-Patron C
Circ Res; 2004 Jan; 94(1):68-76. PubMed ID: 14656925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
